TABLE 3.
Compound | D2 | Reference Ligand | Source | D1 | Reference Ligand | Source | D3 | Reference Ligand | Source | D4 | Reference Ligand | Soursce | D5 | Reference Ligand | Source |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Aripiprazole | 0.59 | 3H-NMSP | Lawler et al. (1999) | 410 | 3H-SCH23390 | Lawler et al. (1999) | 9.7 | 3H-NMSP | Shapiro et al. (2003) | 514 | 3H-NMSP | Besnard et al. (2012) | 1200 | 3H -SCH23390 | Lawler et al. (1999) |
Chlorpromazine | 2 | 3H-NMSP | Besnard et al. (2012) | 112 | 3H-SCH23390 | Besnard et al. (2012) | 1.3 | 3H-raclopride | Seeman (1995) | 24 | 3H-NMSP | Besnard et al. (2012) | 133 | 3H -SCH23390 | Besnard et al. (2012) |
Clomipramine | 77.6 | 3H-spiperone | Millan et al. (2001) | 219 | 3H-SCH23390 | Toll et al. (1998) | 50.1 | 3H-spiperone | Millan et al. (2001) | ||||||
Clozapine | 431 | 3H-NMSP | Besnard et al. (2012) | 189 | 3H-SCH23390 | Besnard et al. (2012) | 340 | 3H-nemonapride | Seeman (1995) | 39 | 3H-NMSP | Besnard et al. (2012) | 235 | 3H -SCH23390 | Besnard et al. (2012) |
Fluphenazine | 0.54 | 3H-NMSP | Besnard et al. (2012) | 24 | 3H-SCH23390 | Besnard et al. (2012) | 0.3 | 3H-nemonapride | Seeman (1995) | 36 | 3H-NMSP | Besnard et al. (2012) | 12 | 3H -SCH23390 | Besnard et al. (2012) |
Haloperidol | 2 | 3H-NMSP | Besnard et al. (2012) | 83 | 3H-SCH23390 | Besnard et al. (2012) | 23 | 3H-nemonapride | Seeman (1995) | 15 | 3H-NMSP | Besnard et al. (2012) | 147 | 3H-SCH23390 | Besnard et al. (2012) |
Olanzapine | 72 | 3H-NMSP | Besnard et al. (2012) | 58 | 3H-SCH23390 | Besnard et al. (2012) | 40 | 3H-nemonipride | Seeman (1995) | 19 | 3H-NMSP | Besnard et al. (2012) | 90 | 3H-SCH23390 | Besnard et al. (2012) |
Penfluridol | 5.6 | 3H-haloperidol | Burt et al. (1976) | 1600* | 3H-dopamine | Burt et al. (1976) | 31** | 3H-spiperone | Roth et al. (1995) | ||||||
Perphenazine | 1.4 | 3H-NMSP | Burt et al. (1976), Kroeze et al. (2003) | 29.9** | 3H-SCH23390 | Billard et al. (1984) | 1.1 | 3H-nemonapride | Seeman (1995) | 32 | 3H-spiperone | Seeman (1995) | |||
Pimozide | 0.65 | 3H-NMSP | Kroeze et al. (2003) | >104 | 3H-SCH23390 | Toll et al. (1998) | 11 | 125I-iodosulpride | Schmidt et al. (1992) | 1.8 | R-SAT | Burstein et al. (2005) | |||
Prochlorperazine | 4 | 3H-spiperone | Seeman (1995) | 1.8 | 125I-iodosulpride | Schmidt et al. (1992) | 70 | 3H-spiperone | Seeman (1995) | ||||||
Risperidone | 4.9 | 3H-NMSP | Besnard et al. (2012) | 60.6 | 3H-SCH23390 | Besnard et al. (2012) | 5.2 | 3H-nemonapride | Seeman (1995) | 18.6 | 3H-NMSP | Besnard et al. (2012) | 16 | 3H-SCH23390 | Besnard et al. (2012) |
SCH 23390 | 2145 | 3H-domperidone | Grandy et al. (1989) | 0.35 | 3H-SCH23390 | Sunahara et al. (1991) | >10,000 | 3H-nemonapride | Neumeyer et al. (2003) | 3560 | 3H-spiperone | Van Tol et al. (1991) | 0.3 | 3H-SCH23390 | Sunahara et al. (1991) |
Spiperone | 0.125 | 3H-domperidone | Grandy et al. (1989) | 577 | 3H-SCH23390 | Sunahara et al. (1991), Toll et al. (1998) | 0.275 | 3H-spiperone | Cussac et al. (2000), Neumeyer et al. (2003) | 4 | 3H-spiperone | Tang et al. (1994) | 4500 | 3H-SCH23390 | Sunahara et al. (1991) |
Thioridazine | 10 | 3H-NMSP | Grandy et al. (1989), Besnard et al. (2012) | 89 | 3H-SCH23390 | Besnard et al. (2012) | 5.2 | 3H-spiperone | Seeman (1995) | 17 | 3H-NMSP | Besnard et al. (2012) | 216 | 3H-SCH23390 | Besnard et al. (2012) |
Trifluoperazine | 1.3 | 3H-NMSP | Kroeze et al. (2003) | 740* | 3H-dopamine | Burt et al. (1976) | 44 | 3H-spiperone | Seeman et al. (1997), Besnard et al. (2012) | ||||||
Unmarked, human receptor. *, calf receptor. **, rat receptor.
Most values and references from the PDSP KI database (https://pdsp.unc.edu/databases/pdsp.php) except for Seeman (1995) and Lawler et al. (1999).